A Pilot Single Center,Randomized,Double Blind Placebo Controlled Study to Assess the Safety,Tolerability and Efficacy of Copaxone in Inducing Remission in Patients With Moderately Active Crohn's Disease.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms Cop1CD
- 01 Mar 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 10 Sep 2008 New trial record.